Koga F - Search Results

1

Renal function after radical nephrectomy: development and validation of predictive models in Japanese patients.

Yokoyama M, Fujii Y, Takeshita H, Kawamura N, Nakayama T, Iimura Y, Sakura M, Ishioka J, Saito K, Koga F, Masuda H, Noro A, Arisawa C, Kitahara S, Kihara K. Yokoyama M, et al. Among authors: koga f. Int J Urol. 2014 Mar;21(3):238-42. doi: 10.1111/iju.12277. Epub 2013 Oct 3. Int J Urol. 2014. PMID: 24118492

2

Serum concentration of type I collagen metabolites as a quantitative marker of bone metastases in patients with prostate carcinoma.

Yoshida K, Sumi S, Arai K, Koga F, Umeda H, Hosoya Y, Honda M, Yano M, Moriguchi H, Kitahara S. Yoshida K, et al. Among authors: koga f. Cancer. 1997 Nov 1;80(9):1760-7. Cancer. 1997. PMID: 9351545

3

Effects of intravenous administration of high dose-diethylstilbestrol diphosphate on serum hormonal levels in patients with hormone-refractory prostate cancer.

Kitahara S, Umeda H, Yano M, Koga F, Sumi S, Moriguchi H, Hosoya Y, Honda M, Yoshida K. Kitahara S, et al. Among authors: koga f. Endocr J. 1999 Oct;46(5):659-64. doi: 10.1507/endocrj.46.659. Endocr J. 1999. PMID: 10670751 Free article.

4

Sarcomatoid renal cell carcinoma with scant carcinomatous components.

Koga F, Kawano K, Honda M, Sumi S, Horimi H, Kondo S, Yoshida K. Koga F, et al. Int J Urol. 2000 Feb;7(2):58-60; discussion 61. doi: 10.1046/j.1442-2042.2000.00134.x. Int J Urol. 2000. PMID: 10710249 Free article.

5

Negative p53/positive p21 immunostaining is a predictor of favorable response to chemotherapy in patients with locally advanced bladder cancer.

Koga F, Kitahara S, Arai K, Honda M, Sumi S, Yoshida K. Koga F, et al. Jpn J Cancer Res. 2000 Apr;91(4):416-23. doi: 10.1111/j.1349-7006.2000.tb00961.x. Jpn J Cancer Res. 2000. PMID: 10804290 Free PMC article.

6

Endoscopic minilaparotomy partial nephrectomy for solitary renal cell carcinoma smaller than 4 cm.

Kageyama Y, Kihara K, Yokoyama M, Sakai Y, Koga F, Saito K, Yano M, Arai G, Hyochi N, Masuda H, Fujii Y, Kawakami S, Kobayashi T. Kageyama Y, et al. Among authors: koga f. Jpn J Clin Oncol. 2002 Oct;32(10):417-21. doi: 10.1093/jjco/hyf087. Jpn J Clin Oncol. 2002. PMID: 12451039

7

Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms.

Koga F, Kawakami S, Kumagai J, Takizawa T, Ando N, Arai G, Kageyama Y, Kihara K. Koga F, et al. Br J Cancer. 2003 Mar 10;88(5):740-7. doi: 10.1038/sj.bjc.6600764. Br J Cancer. 2003. PMID: 12618884 Free PMC article.

8

Increased expression of sialyl-Lewis A correlates with poor survival in upper urinary tract urothelial cancer patients.

Saito K, Fujii Y, Kawakami S, Hayashi T, Arisawa C, Koga F, Kageyama Y, Kihara K. Saito K, et al. Among authors: koga f. Anticancer Res. 2003 Jul-Aug;23(4):3441-6. Anticancer Res. 2003. PMID: 12926087

9

Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential.

Fujii Y, Kawakami S, Koga F, Nemoto T, Kihara K. Fujii Y, et al. Among authors: koga f. BJU Int. 2003 Oct;92(6):559-62. doi: 10.1046/j.1464-410x.2003.04415.x. BJU Int. 2003. PMID: 14511033

10

Favorable outcome of preoperative low dose chemoradiotherapy against muscle-invasive bladder cancer.

Kageyama Y, Yokoyama M, Sakai Y, Saito K, Koga F, Yano M, Arai G, Hyochi N, Masuda H, Fujii Y, Kawakami S, Kobayashi T, Kihara K. Kageyama Y, et al. Among authors: koga f. Am J Clin Oncol. 2003 Oct;26(5):504-7. doi: 10.1097/01.coc.0000037665.11701.22. Am J Clin Oncol. 2003. PMID: 14528080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters